By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Nick Conley is Principal Scientist for Locus Biosciences.
Talks About #cmc #longevity #biopharmaceuticals #antibioticresistance
Preferred Locations #NorthAmerica
Phage therapies have shown promise in compassionate use, but limited success of double blind randomised controlled trials has slowed progression through the clinic.